Too Old to Operate8h
Longitudinal Study of Genetic Risk in Renal and Non-Renal Lupus
The following is a summary of “Distinct genetic risk loci between biopsy-proven renal and non-renal lupus: a 10-year ...
Too Old to Operate8h
Predicting Proliferative LN in Patients With Low-Level Proteinuria
The following is a summary of “Nomogram for predicting proliferative lupus nephritis in patients with low-level proteinuria,” ...
Deccan Chronicle13d
IIIT-H, NIMS launch India’s first pathology dataset
Hyderabad:IIIT Hyderabad (IIIT-H) and Nizam’s Institute of Medical Sciences (NIMS) have launched India’s first publicly ...
The Times of India on MSN12d
IIIT-Hyderabad, NIMS launch digital pathology datasets for brain cancer & lupus research
The effort, dubbed India Pathology Dataset (IPD) project, a collaborative initiative involving academia, hospitals, industry, ...
To help with better disease diagnosis and treatment, two institutes in Hyderabad collaborate to launch digital pathology datasets
Enhancing clinical research in India with publicly accessible histopathological image datasets for cancer and kidney disease ...
thecardiologyadvisor.com11d
SGLT2 Inhibitors Provide Cardiorenal Benefits for Patients With SLE and Type 2 Diabetes
The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.
lupus.bmj10d
Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis
in proliferative lupus nephritis (LN) patients who discontinued immunosuppressive therapy (IST), as well as the long-term renal outcomes following RR. Methods Retrospective, single-centre study of ...
BMJ20d
Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial
Objectives Lupus nephritis (LN) is a frequent complication of systemic ... Suspected renal relapse involved a kidney biopsy to confirm (class III or class IV LN with active lesions, with or without ...
BMJ26d
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Proliferative lupus nephritis (LN) is the most common severe organ-threatening ... baseline UPCR ≥3 and those with class IV (as compared with class III) LN on renal biopsy (table 2). While ...